Cerebrovascular Disease Clinical Trial
Official title:
Effects of Nutritional Counseling Regularity on the Risk of Cardiovascular Diseases
NCT number | NCT05092087 |
Other study ID # | N202103134 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | April 21, 2021 |
Est. completion date | May 31, 2021 |
Verified date | April 2021 |
Source | Taipei Medical University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This study aims to investigate the frequency of personalized nutrition counseling's effect on individual cardiovascular risk factors. The study collected 110 to 150 cases data, including a regular blood test, blood glucose, blood lipid, liver panel, and inflammatory factors. The enrolled cases were classified into two groups according to the subjects' duration of consultation: those who completed the consultation and subsequent tests in >24 weeks were in the control group, whereas those who completed the consultation and subsequent tests in <24 weeks were in the test group. The effectiveness of nutrition consultation toward managing cardiovascular disease risk factors and its correlation with the subjects' frequency of following the consultations was analyzed using the pre- and post-consultation data. It was found that personalized nutrition consultation significantly improved the subjects' risk factors of cardiovascular diseases, and that the treatment group showed a greater improvement than the control group which who require over 24 weeks to complete all consultation sessions.
Status | Completed |
Enrollment | 129 |
Est. completion date | May 31, 2021 |
Est. primary completion date | May 31, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 20 Years and older |
Eligibility | Inclusion Criteria: - Age ? 20 - Anyone of follow: body mass index > 24 systolic blood pressure > 120 mmHg diastolic blood pressure > 80 mmHg triglyceride > 150 mg/dL fasting blood glucose >100 mg/dL Exclusion Criteria: - Age <20 - pregnant - Mental problem - unable to do the measurement of body composition - incomplete the nutritional counseling program |
Country | Name | City | State |
---|---|---|---|
Taiwan | Taipei Medical University | Taipei |
Lead Sponsor | Collaborator |
---|---|
Taipei Medical University |
Taiwan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | body weight | body weight in kilograms | baseline, pre-intervention | |
Primary | body weight | body weight in kilograms | immediately after the intervention | |
Primary | height | height in meters | baseline, pre-intervention | |
Primary | height | height in meters | immediately after the intervention | |
Primary | body mass index | body mass index in kg/m^2 | baseline, pre-intervention | |
Primary | body mass index | body mass index in kg/m^2 | immediately after the intervention | |
Primary | body fat | body fat in ratio | baseline, pre-intervention | |
Primary | body fat | body fat in ratio | immediately after the intervention | |
Primary | The concentration of blood triglyceride | blood triglyceride in mg/dL | baseline, pre-intervention | |
Primary | The concentration of blood total cholesterol | blood total cholesterol in mg/dL | within one week after the intervention | |
Primary | The concentration of blood low density lipoprotein-cholesterol | blood blood low density lipoprotein-cholesterol in mg/dL | baseline, pre-intervention | |
Primary | The concentration of blood low density lipoprotein-cholesterol | blood blood low density lipoprotein-cholesterol in mg/dL | within one week after the intervention | |
Primary | The concentration of blood high density lipoprotein-cholesterol-cholesterol | blood high density lipoprotein-cholesterol in mg/dL | baseline, pre-intervention | |
Primary | The concentration of blood high density lipoprotein-cholesterol-cholesterol | blood high density lipoprotein-cholesterol in mg/dL | within one week after the intervention | |
Primary | The concentration of blood high sensitive C-reactive protein | blood high sensitive sensitive C-reactive protein in mg/L | baseline, pre-intervention | |
Primary | The concentration of blood high sensitive C-reactive protein | blood high sensitive sensitive C-reactive protein in mg/L | within one week after the intervention | |
Primary | The concentration of blood fasting glucose | blood fasting glucose in mg/dL | baseline, pre-intervention | |
Primary | The concentration of blood fasting glucose | blood fasting glucose in mg/dL | within one week after the intervention | |
Primary | blood HbA1C | blood HbA1C in percentage | baseline, pre-intervention | |
Primary | blood HbA1C | blood HbA1C in percentage | within one week after the intervention | |
Primary | The concentration of blood insulin | blood insulin in mg/dL | baseline, pre-intervention | |
Primary | The concentration of blood insulin | blood insulin in mg/dL | within one week after the intervention | |
Primary | The activity of blood aspartate aminotransferase | blood aspartate aminotransferase in U/L | baseline, pre-intervention | |
Primary | The activity of blood aspartate aminotransferase | blood aspartate aminotransferase in U/L | within one week after the intervention | |
Primary | The activity of blood alanine aminotransferase | blood alanine aminotransferase in U/L | baseline, pre-intervention | |
Primary | The activity of blood alanine aminotransferase | blood alanine aminotransferase in U/L | within one week after the intervention | |
Primary | The concentration of blood urinary nitrogen (BUN) | BUN in mg/L | baseline, pre-intervention | |
Primary | The concentration of blood urinary nitrogen (BUN) | BUN in mg/L | within one week after the intervention | |
Primary | The concentration of blood creatinine | BUN in mg/dL | baseline, pre-intervention | |
Primary | The concentration of blood creatinine | BUN in mg/dL | within one week after the intervention | |
Primary | The concentration of blood uric acid | blood uric acid in mg/dL | baseline, pre-intervention | |
Primary | The concentration of blood uric acid | blood uric acid in mg/dL | within one week after the intervention | |
Primary | The concentration of blood total protein | blood uric acid in mg/dL | baseline, pre-intervention | |
Primary | The concentration of blood total protein | blood uric acid in mg/dL | within one week after the intervention | |
Primary | The concentration of blood albumin | blood uric acid in mg/dL | baseline, pre-intervention | |
Primary | The concentration of blood albumin | blood uric acid in mg/dL | within one week after the intervention | |
Primary | The concentration of blood globulin | blood uric acid in mg/dL | baseline, pre-intervention | |
Primary | The concentration of blood globulin | blood uric acid in mg/dL | within one week after the intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT02248311 -
"Preventing Cardiovascular Ischemic Events and Arresting Their Consequences in Type 2 Diabetic Population
|
N/A | |
Completed |
NCT01604486 -
Natural Ischaemic Preconditioning Before First Myocardial Infarction
|
N/A | |
Active, not recruiting |
NCT00627029 -
Evaluation of Programs of Coordinated Care and Disease Management
|
N/A | |
Recruiting |
NCT04336852 -
Development of a Clinically-relevant Test for Assessment of Cerebral Vascular Function
|
N/A | |
Not yet recruiting |
NCT06429332 -
International Care Bundle Evaluation in Cerebral Hemorrhage Research
|
Phase 4 | |
Not yet recruiting |
NCT05925699 -
National Database of the Virtual Institute of Cerebrovascular Diseases
|
||
Recruiting |
NCT04443439 -
Assess the Risk of Cerebrovascular Disease
|
||
Recruiting |
NCT04525144 -
EGb 761 in the Syndrome of MCI With Concomitant CVD
|
Phase 2 | |
Completed |
NCT02553655 -
Remote Ischemic Limb Preconditioning In Healthy Volunteers
|
N/A | |
Recruiting |
NCT00385385 -
RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease
|
Phase 2 | |
Recruiting |
NCT05247931 -
Why Does Aspirin Fail in Secondary Cerebrovascular Prevention? A Multicenter Prospective Case - Control Study
|
||
Completed |
NCT02665585 -
Plaque Prolapse Prevention Carotid Artery Stenting (3PCAS)
|
N/A | |
Recruiting |
NCT05834673 -
VICTORION-ASCERTAIN: Implementation Study (v-ASCERTAIN)
|
Phase 4 | |
Recruiting |
NCT06115213 -
The North Kynouria Project
|
N/A | |
Recruiting |
NCT02730065 -
Aerobic Dance Training in Small Vessel Disease
|
N/A | |
Terminated |
NCT02440646 -
Natural History of Coronary Atherosclerosis in Real-World Stable Chest Pain Patients Underwent Computed Tomography Angiography in Comparison With Invasive Multimodality Imaging
|
||
Completed |
NCT01924312 -
Early Detection and Prevention of Mild Cognitive Impairment Due to Cerebrovascular Disease
|
N/A | |
Completed |
NCT00333164 -
Cilostazol-Aspirin Therapy Against Recurrent Stroke With Intracranial Artery Stenosis
|
Phase 3 | |
Not yet recruiting |
NCT06241482 -
Safety and Efficacy of Enhanced Recovery After Surgery in Neurocritical Care
|
N/A | |
Enrolling by invitation |
NCT02694094 -
Impact of Ketogenic Diets on Cardiovascular Health in Adults With Epilepsy
|